Dow on Track to Finish Best Month in 33 Years
November 30 2020 - 6:03AM
Dow Jones News
By Joe Wallace
U.S. stocks are on track to complete a banner November, giving
the Dow its best month in over 33 years, as investors cheer the
prospect of Covid-19 vaccines halting the pandemic and fresh
stimulus spending to bolster the economy.
Futures tied to the Dow Jones Industrial Average ticked down
0.5% Monday, signaling that the blue-chips index will enter the
final trading session of November on a muted note. The benchmark
was up roughly 12.9% month-to-date by the end of Friday.
Contracts linked to the S&P 500 slipped 0.4% at the start of
the week, while technology-heavy Nasdaq-100 futures were largely
flat, suggesting that stocks across the board are likely to take a
breather after last week's sharp rally. The S&P 500 and Nasdaq
Composite remain on track for what may be their biggest monthly
advance since April.
Stocks have soared in November, at one point pushing the Dow
over 30000 for the first time and putting the benchmark on course
for potentially its biggest one-month advance since January 1987.
Shares in companies that had suffered most from the pandemic, such
as energy producers and banks, have posted steep gains.
The Russell 2000 index of small-cap stocks is also on pace for
its best month in data going back to 1987.
Two main factors have fueled the latest leg up in markets,
according to investors. The development of three vaccines in the
West has opened up the possibility that the economic disruption
caused by the coronavirus will end in 2021. Signs that
President-elect Joe Biden will make a relatively smooth transition
into the White House have doused some of the political uncertainty
that had fed into heightened market volatility in the fall.
The looming rollout of vaccines is likely to keep stocks on an
upward trajectory in the final weeks of the year, investors and
analysts said.
The surge of coronavirus infection in the U.S. and the
possibility for logistical hiccups in the distribution of the shots
could lead to bouts of selling. Still, money managers expect
investors to view any declines as a buying opportunity.
"We've got a lot of very good vaccine news," said Daniel Morris,
chief market strategist at BNP Paribas Asset Management. "We
should, for the most part, move up between now and the end of the
year, with a chance for a setback here or there.
One risk for stocks in the coming months stems from exuberance
among individual investors, said Trevor Greetham, head of multi
asset at Royal London Asset Management, pointing to surveys by the
American Association of Individual Investors. Still, the U.K. asset
manager is betting that a revival in economic activity will
continue to buoy stock prices in 2021.
The prospect of vaccines offers "some light at the end of the
tunnel as an investor," Mr. Greetham said. "If you're buying
stocks, you're not just assessing the next month or two -- you're
assessing the next 20 years."
Ahead of the bell in New York, shares in S&P Global fell 2%
after The Wall Street Journal reported that the data provider is
nearing a deal to acquire IHS Markit for about $44 billion. The
all-stock deal, which at that price would be the largest of the
year, could be announced as soon as Monday. Shares in IHS Market
jumped 8%.
In bond markets, the yield on 10-year Treasurys ticked up to
0.844%, from 0.841% on Friday.
Brent-crude futures fell 2% to $47.27 a barrel, after reports
that ministers from the Organization of the Petroleum Exporting
Countries and its allies were yet to agree on delaying a boost to
production in January ahead of meetings Monday and Tuesday.
Traders broadly expect the cartel to extend output curbs into
2021 to bolster prices amid surging virus cases in the U.S. and
restrictions on travel in Europe.
In Asia, investors were rattled by a Reuters report that the
Trump administration is poised to add oil producer Cnooc and chip
maker Semiconductor Manufacturing International to a blacklist of
alleged Chinese military companies. Cnooc shares tumbled 14% in
Hong Kong, while SMIC's Hong Kong-listed stock fell 2.7%.
Most major markets in the region ended lower. Hong Kong's Hang
Seng lost 2.1%, Japan's Nikkei 225 retreated 0.8% and the Shanghai
Composite Index lost 0.5%.
Markets are concerned about more restrictions from the U.S. on
investing in Chinese companies, according to Steven Leung,
executive director of institutional sales at UOB Kay Hian in Hong
Kong.
"Some investors would rather stay on the sidelines awaiting more
clarity on vaccine developments and U.S. policy directions as the
nation transits to new leadership," Mr. Leung said.
Banks and energy producers dropped in Europe, leading the Stoxx
Europe 600 down less than 0.1%. Shares in UniCredit fell 4.1% on
reports that the board was holding talks about governance at the
Italian bank.
--Joanne Chiu contributed to this article.
Write to Joe Wallace at Joe.Wallace@wsj.com
(END) Dow Jones Newswires
November 30, 2020 05:48 ET (10:48 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.